Skip to main content
Top
Published in: Journal of Clinical Immunology 1/2010

01-01-2010

Rheumatic Fever and Rheumatic Heart Disease: Cellular Mechanisms Leading Autoimmune Reactivity and Disease

Authors: Luiza Guilherme, Jorge Kalil

Published in: Journal of Clinical Immunology | Issue 1/2010

Login to get access

Abstract

Introduction

Rheumatic fever (RF) is an autoimmune disease caused by the gram-positive bacteria Streptococcus pyogenes that follows a nontreated throat infection in susceptible children. The disease manifests as polyarthritis, carditis, chorea, erythema marginatum, and/or subcutaneous nodules. Carditis, the most serious complication, occurs in 30% to 45% of RF patients and leads to chronic rheumatic heart disease (RHD), which is characterized by progressive and permanent valvular lesions. In this review, we will focus on the genes that confer susceptibility for developing the disease, as well as the innate and adaptive immune responses against S. pyogenes during the acute rheumatic fever episode that leads to RHD autoimmune reactions.

Discussion

The disease is genetically determined, and some human leukocyte antigen class II alleles are involved with susceptibility. Other single nucleotide polymorphisms for TNF-alpha and mannan-binding lectin genes were reported as associated with RF/RHD. T cells play an important role in RHD heart lesions. Several autoantigens were already identified, including cardiac myosin epitopes, vimentin, and other intracellular proteins. In the heart tissue, antigen-driven oligoclonal T cell expansions were probably the effectors of the rheumatic heart lesions. These cells are CD4+ and produced inflammatory cytokines (TNFα and IFNγ).

Conclusion

Molecular mimicry is the mechanism that mediated the cross-reactions between streptococcal antigens and human proteins. The elucidation of chemokines and their receptors involved with the recruitment of Th1, Th2, and Th17 cells, as well as the function of T regulatory cells in situ will certainly contribute to the delineation of the real picture of the heart lesion process that leads to RHD.
Literature
1.
go back to reference Dajani AS, Ayoub E, Bierman FZ, et al. Guidelines for the diagnosis of rheumatic fever: Jones criteria, 1992 uptade. JAMA. 1992;268:2069–73.CrossRef Dajani AS, Ayoub E, Bierman FZ, et al. Guidelines for the diagnosis of rheumatic fever: Jones criteria, 1992 uptade. JAMA. 1992;268:2069–73.CrossRef
2.
go back to reference Carapetis JR, Mulholland SAC, EK WM. The global burden of group A streptococcal disease. Lancet Infect Dis. 2005;5:685–94.CrossRefPubMed Carapetis JR, Mulholland SAC, EK WM. The global burden of group A streptococcal disease. Lancet Infect Dis. 2005;5:685–94.CrossRefPubMed
3.
go back to reference Guilherme L, Ramasawmy R, Kalil J. Rheumatic fever and rheumatic heart disease: genetics and pathogenesis. Scand J Immunol. 2007;66:199–207.CrossRefPubMed Guilherme L, Ramasawmy R, Kalil J. Rheumatic fever and rheumatic heart disease: genetics and pathogenesis. Scand J Immunol. 2007;66:199–207.CrossRefPubMed
4.
go back to reference Stanevicha V, Eglite J, Sochnevs A, Gardovska D, Zavadska D, Shantere R. HLA class II associations with rheumatic heart disease among clinically homogeneous patients in children in Latvia. Arthritis Res Ther. 2003;5:R340–6.CrossRefPubMed Stanevicha V, Eglite J, Sochnevs A, Gardovska D, Zavadska D, Shantere R. HLA class II associations with rheumatic heart disease among clinically homogeneous patients in children in Latvia. Arthritis Res Ther. 2003;5:R340–6.CrossRefPubMed
5.
go back to reference Hernandez-Pacheco G, Flores-Dominguez C, et al. Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with rheumatic heart disease. J Autoimmun. 2003;21:59–63.CrossRefPubMed Hernandez-Pacheco G, Flores-Dominguez C, et al. Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with rheumatic heart disease. J Autoimmun. 2003;21:59–63.CrossRefPubMed
6.
go back to reference Ramasawmy R, Fae KC, Spina G, et al. Association of polymorphisms within the promoter region of the tumor necrosis factor-alpha with clinical outcomes of rheumatic fever. Mol Immunol. 2007;44:1873–8.CrossRefPubMed Ramasawmy R, Fae KC, Spina G, et al. Association of polymorphisms within the promoter region of the tumor necrosis factor-alpha with clinical outcomes of rheumatic fever. Mol Immunol. 2007;44:1873–8.CrossRefPubMed
7.
go back to reference Jack DL, Klein NJ, Turner MW. Mannose-binding lectin: targeting the microbial world for complement attack and opsonophagocytosis. Immunol Rev. 2001;180:86–99.CrossRefPubMed Jack DL, Klein NJ, Turner MW. Mannose-binding lectin: targeting the microbial world for complement attack and opsonophagocytosis. Immunol Rev. 2001;180:86–99.CrossRefPubMed
8.
go back to reference Messias Reason IJ, Schafranski MD, Jensenius JC, Steffensen R. The association between mannose-binding lectin gene polymorphism and rheumatic heart disease. Hum Immunol. 2006;67:991–8.CrossRefPubMed Messias Reason IJ, Schafranski MD, Jensenius JC, Steffensen R. The association between mannose-binding lectin gene polymorphism and rheumatic heart disease. Hum Immunol. 2006;67:991–8.CrossRefPubMed
9.
go back to reference Schafranski MD, Pereira-Ferrari L, Scherner D, Messias-Reason IJ. High-producing MBL2 genotypes increase the risk of acute and chronic carditis in patients with history of rheumatic fever. Mol Immunol. 2008;45(14):3827–31.CrossRefPubMed Schafranski MD, Pereira-Ferrari L, Scherner D, Messias-Reason IJ. High-producing MBL2 genotypes increase the risk of acute and chronic carditis in patients with history of rheumatic fever. Mol Immunol. 2008;45(14):3827–31.CrossRefPubMed
10.
go back to reference Ramasawmy R, Spina G, Faé KC, Perreira AC et al. Association of mannosebinding lectin gene polymorphism but not of mannose-binding serine protease-2 with chronic severe aortic regurgitation of rheumatic etiology. Clinical and Vaccine Immunology. 2008;15(6):932-6.CrossRefPubMed Ramasawmy R, Spina G, Faé KC, Perreira AC et al. Association of mannosebinding lectin gene polymorphism but not of mannose-binding serine protease-2 with chronic severe aortic regurgitation of rheumatic etiology. Clinical and Vaccine Immunology. 2008;15(6):932-6.CrossRefPubMed
11.
go back to reference Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev. 2000;13:470–511.CrossRefPubMed Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev. 2000;13:470–511.CrossRefPubMed
12.
go back to reference Guilherme L, Kalil J, Cunningham MW. Molecular mimicry in the autoimmune pathogenesis of rheumatic heart disease. Autoimmunity. 2006;39(1):31–9.CrossRefPubMed Guilherme L, Kalil J, Cunningham MW. Molecular mimicry in the autoimmune pathogenesis of rheumatic heart disease. Autoimmunity. 2006;39(1):31–9.CrossRefPubMed
13.
go back to reference Lehmann PV, Forsthuber T, Miller A, Sercarz EE. Spreading of T cell autoimmunity to cryptic determinants of an autoantigen. Nature. 1992;359:155–7.CrossRef Lehmann PV, Forsthuber T, Miller A, Sercarz EE. Spreading of T cell autoimmunity to cryptic determinants of an autoantigen. Nature. 1992;359:155–7.CrossRef
14.
go back to reference Raizada V, Williams RC Jr, Chopra P, et al. Tissue distribution of lymphocytes in rheumatic heart valves as defined by monoclonal anti-T cell antibodies. Am J Med. 1983;74:90–6.CrossRefPubMed Raizada V, Williams RC Jr, Chopra P, et al. Tissue distribution of lymphocytes in rheumatic heart valves as defined by monoclonal anti-T cell antibodies. Am J Med. 1983;74:90–6.CrossRefPubMed
15.
go back to reference Kemeny E, Grieve T, Marcus R, Sareli P, Zabriskie JB. Identification of mononuclear cells and T cell subsets in rheumatic valvulitis. Clin Immunol Immunopathol. 1989;52:225–37.CrossRefPubMed Kemeny E, Grieve T, Marcus R, Sareli P, Zabriskie JB. Identification of mononuclear cells and T cell subsets in rheumatic valvulitis. Clin Immunol Immunopathol. 1989;52:225–37.CrossRefPubMed
16.
go back to reference Guilherme L, Weidebach W, Kiss MH, Snitcowsky R, Kalil J. Association of human leukocyte class II antigens with rheumatic fever or rheumatic heart disease in a Brazilian population. Circulation. 1991;83:1995–8.PubMed Guilherme L, Weidebach W, Kiss MH, Snitcowsky R, Kalil J. Association of human leukocyte class II antigens with rheumatic fever or rheumatic heart disease in a Brazilian population. Circulation. 1991;83:1995–8.PubMed
17.
go back to reference Galvin JE, Hemric ME, Ward K, Cunnimgham M. Cytotoxic monoclonal antibody from rheumatic carditis reacts with human endothelium: implicxations in rheumatic heart disease. J Clin Invest. 2000;106:217–24.CrossRefPubMed Galvin JE, Hemric ME, Ward K, Cunnimgham M. Cytotoxic monoclonal antibody from rheumatic carditis reacts with human endothelium: implicxations in rheumatic heart disease. J Clin Invest. 2000;106:217–24.CrossRefPubMed
18.
go back to reference Roberts S, Kosanke S, Dun TS, et al. Pathogenic mechanism in rheumatic carditis: focus on valvular endothelium. J Infect Diseases. 2001;183:507–11.CrossRef Roberts S, Kosanke S, Dun TS, et al. Pathogenic mechanism in rheumatic carditis: focus on valvular endothelium. J Infect Diseases. 2001;183:507–11.CrossRef
19.
go back to reference Fae KC, da Silva DD, Oshiro SE, et al. Mimicry in recognition of cardiac myosin peptides by heart-intralesional T cell clones from rheumatic heart disease. J Immunol. 2006;176:5662–70.PubMed Fae KC, da Silva DD, Oshiro SE, et al. Mimicry in recognition of cardiac myosin peptides by heart-intralesional T cell clones from rheumatic heart disease. J Immunol. 2006;176:5662–70.PubMed
20.
go back to reference Guilherme L, Oshiro SE, Fae KC, Cunha-Neto E, et al. T cell reactivity against streptococcal antigens in the periphery mirrors reactivity of heart-infiltrating T lymphocytes in rheumatic heart disease patients. Infect Immun. 2001;69:5345–51.CrossRefPubMed Guilherme L, Oshiro SE, Fae KC, Cunha-Neto E, et al. T cell reactivity against streptococcal antigens in the periphery mirrors reactivity of heart-infiltrating T lymphocytes in rheumatic heart disease patients. Infect Immun. 2001;69:5345–51.CrossRefPubMed
21.
go back to reference Yoshinaga M, Figueiroa F, Wahid MR, Marcus RH, Suh E, Zabriskie JB. Antigenic specificity of lymphocytes isolated from valvular specimens of rheumatic fever patients. J Autoimmun. 1995;8:601–13.CrossRefPubMed Yoshinaga M, Figueiroa F, Wahid MR, Marcus RH, Suh E, Zabriskie JB. Antigenic specificity of lymphocytes isolated from valvular specimens of rheumatic fever patients. J Autoimmun. 1995;8:601–13.CrossRefPubMed
22.
23.
go back to reference Ellis NM, Li Y, Hildebrand W, Fischetti VA, Cunningham MW. T cell mimicry and epitope specificity of cross-reactive T cell clones from rheumatic heart disease. J Immunol. 2005;175:5448–56.PubMed Ellis NM, Li Y, Hildebrand W, Fischetti VA, Cunningham MW. T cell mimicry and epitope specificity of cross-reactive T cell clones from rheumatic heart disease. J Immunol. 2005;175:5448–56.PubMed
24.
go back to reference Lievremont JP, Rizzuto R, Hendershot L, BiP MJ. A major chaperone protein of the endoplasmic reticulum lumen, plays a direct and important role in the storage of the rapidly exchanging pool of Ca2+. J Biol Chem. 1997;272:30873–9.CrossRefPubMed Lievremont JP, Rizzuto R, Hendershot L, BiP MJ. A major chaperone protein of the endoplasmic reticulum lumen, plays a direct and important role in the storage of the rapidly exchanging pool of Ca2+. J Biol Chem. 1997;272:30873–9.CrossRefPubMed
25.
go back to reference Little E, Ramakrishnan M, Roy B, Gazita G, Lee AS. The glucose-regulated proteins (GRP78 and GRP94): functions, gene regulation, and applications. Crit Rev Eukaryot Gene Expr. 1994;4:1–18.PubMed Little E, Ramakrishnan M, Roy B, Gazita G, Lee AS. The glucose-regulated proteins (GRP78 and GRP94): functions, gene regulation, and applications. Crit Rev Eukaryot Gene Expr. 1994;4:1–18.PubMed
26.
go back to reference Nigam SK, Goldberg AL, Ho S, Rohde MF, Bush KT, Sherman M. A set of endoplasmic reticulum proteins possessing properties of molecular chaperones includes Ca(2+)-binding proteins and members of the thioredoxin superfamily. J Biol Chem. 1994;269:1744–9.PubMed Nigam SK, Goldberg AL, Ho S, Rohde MF, Bush KT, Sherman M. A set of endoplasmic reticulum proteins possessing properties of molecular chaperones includes Ca(2+)-binding proteins and members of the thioredoxin superfamily. J Biol Chem. 1994;269:1744–9.PubMed
27.
go back to reference Guilherme L, Dulphy N, Douay C, Coelho V, Cunha-Neto E, et al. Molecular evidence for antigen-driven immune responses in cardiac lesions of Rheumatic Heart Disease patients. Int Immunol. 2000;12:1063–74.CrossRefPubMed Guilherme L, Dulphy N, Douay C, Coelho V, Cunha-Neto E, et al. Molecular evidence for antigen-driven immune responses in cardiac lesions of Rheumatic Heart Disease patients. Int Immunol. 2000;12:1063–74.CrossRefPubMed
28.
go back to reference Faé K, Kalil J, Toubert A, Guilherme L. Heart-infiltrating T cell clones from a rheumatic heart disease patient display a common TCR usage and a degenerate antigen recognition pattern. Mol Immunol. 2004;40(14–15):1129–35.CrossRefPubMed Faé K, Kalil J, Toubert A, Guilherme L. Heart-infiltrating T cell clones from a rheumatic heart disease patient display a common TCR usage and a degenerate antigen recognition pattern. Mol Immunol. 2004;40(14–15):1129–35.CrossRefPubMed
29.
go back to reference Guilherme L, Faé K, Oshiro SE, Kalil J. (2005) Molecular pathogenesis of rheumatic fever and rheumatic heart disease. Exp Rev Mol Immunol (7):1–15. On line access. doi: 10.1017/S146239940501015X Guilherme L, Faé K, Oshiro SE, Kalil J. (2005) Molecular pathogenesis of rheumatic fever and rheumatic heart disease. Exp Rev Mol Immunol (7):1–15. On line access. doi: 10.​1017/​S146239940501015​X
30.
go back to reference Guilherme L, Cury P, Demarchi LM, et al. Rheumatic heart disease: proinflammatory cytokines play a role in the progression and maintenance of valvular lesions. Am J Pathol. 2004;165:1583–91.PubMed Guilherme L, Cury P, Demarchi LM, et al. Rheumatic heart disease: proinflammatory cytokines play a role in the progression and maintenance of valvular lesions. Am J Pathol. 2004;165:1583–91.PubMed
31.
go back to reference Ivanov II, Mckenzie BS, Zhou L, Tadokoro CE, et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell. 2006;126:1121–33.CrossRefPubMed Ivanov II, Mckenzie BS, Zhou L, Tadokoro CE, et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell. 2006;126:1121–33.CrossRefPubMed
32.
go back to reference Annunziato F, Cosmi L, Santarlasci V, Maggi L, et al. Phenotypic and funcational features of human Th17 cells. J Exp Med. 2007;204(8):1849–61.CrossRefPubMed Annunziato F, Cosmi L, Santarlasci V, Maggi L, et al. Phenotypic and funcational features of human Th17 cells. J Exp Med. 2007;204(8):1849–61.CrossRefPubMed
Metadata
Title
Rheumatic Fever and Rheumatic Heart Disease: Cellular Mechanisms Leading Autoimmune Reactivity and Disease
Authors
Luiza Guilherme
Jorge Kalil
Publication date
01-01-2010
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 1/2010
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-009-9332-6

Other articles of this Issue 1/2010

Journal of Clinical Immunology 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.